The global bovine respiratory disease treatment market size was valued at USD 69 million in 2021 and is poised to grow at a significant CAGR of 5% during the forecast period 2022-28. BRD is the most frequent disease in cattle, affecting the lower respiratory system and producing bronchopneumonia, which can lead to mortality. It's a multi-factorial condition that's triggered by the combination of a viral infection and a bacterial agent, and is exacerbated by stress. Pasteurella multocida, Haemophilus somnus, and Mannheimia haemolytica are among the bacteria that cause BRD, as are viral agents such infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhoea (BVD), and parainfluenza type-3 virus (PI-3).

View detailed report description here     

The global bovine respiratory disease treatment market segmentation:
1) By Disease Type: lower RTI, upper RTI, and Diphtheria.
2) By Treatment Type: Vaccines, Antibiotics, NSAIDs, Immuno-modulators
3) By End User: Veterinary hospitals, Clinics, Research institutes, and Private veterinaries.

The key drivers driving the market examined are increased beef consumption and a growing population. Beef consumption is on the rise all across the world, thanks to increased population and disposable income. Due to calf mortality, increased labour costs, and treatment expenditures, bovine respiratory disease (BRD) has a severe impact on both the dairy and beef industries. BRD also has a negative impact on cattle's reproductive performance, growth, and lifespan. As a result, BRD treatment is in high demand on the market. Furthermore, to fulfil the rising demand for beef, most countries throughout the world are increasing cattle meat output. The rising demand for beef, combined with greater production, results in an ever-increasing supply. The diagnosis of BRD comes with a number of difficulties. Depression, weight loss, cough, mucopurulent and purulent nasal discharge, temperature, increased respiratory rate, and altered pulmonary sound on auscultation are common indications of BRD in animals. Due to the similarity of clinical indications and the variety of potential microorganisms, making a presumptive diagnosis following a physical examination is difficult. As a result, the difficult diagnosis technique is limiting market expansion.

Request sample report at                                                                                         

Owing to the rising frequency of bovine respiratory illness in the region, North America is likely to have a dominating position in the bovine respiratory disease treatment market. Bovine respiratory disease (BRD) is a worldwide health concern that is highly widespread among cattle in North America, according to the 2014 Bovine Respiratory Disease Symposium. In the United States, BRD is responsible for 75-85 percent of all feedlot morbidity and 45-55 percent of all death. Due to increased cow rearing in China, the bovine respiratory disease market in Asia Pacific is predicted to rise significantly. According to a 2017 report issued by the United States Department of Agriculture, China is the world's second-largest exporter of beef meat.

The bovine respiratory disease treatment market key players are AgriLabs, Bayer AG HealthCare, Bimeda Animal Health, Boehringer Ingelheim International GmbH, Ceva, Elanco

Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll - Free: +1 866 598 1553
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747